Literature DB >> 17638831

Surgical embolus removal in retinal artery occlusion.

Sohan Singh Hayreh.   

Abstract

Entities:  

Mesh:

Year:  2007        PMID: 17638831      PMCID: PMC1954823     

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Central retinal artery occlusion: visual outcome.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258

Review 2.  Prevalent misconceptions about acute retinal vascular occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2005-07       Impact factor: 21.198

3.  Surgical embolus removal in retinal artery occlusion.

Authors:  J García-Arumí; V Martinez-Castillo; A Boixadera; A Fonollosa; B Corcostegui
Journal:  Br J Ophthalmol       Date:  2006-07-19       Impact factor: 4.638

4.  Central retinal artery occlusion. Retinal survival time.

Authors:  Sohan Singh Hayreh; M Bridget Zimmerman; Alan Kimura; Ashish Sanon
Journal:  Exp Eye Res       Date:  2004-03       Impact factor: 3.467

Review 5.  Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature.

Authors:  Sohan Singh Hayreh; Bridget Zimmerman; Randy H Kardon
Journal:  Acta Ophthalmol Scand       Date:  2002-08
  5 in total
  3 in total

Review 1.  Ocular vascular occlusive disorders: natural history of visual outcome.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2014-04-21       Impact factor: 21.198

2.  Acute retinal arterial occlusive disorders.

Authors:  Sohan Singh Hayreh
Journal:  Prog Retin Eye Res       Date:  2011-05-19       Impact factor: 21.198

3.  Branch retinal artery occlusion: natural history of visual outcome.

Authors:  Sohan Singh Hayreh; Patricia A Podhajsky; M Bridget Zimmerman
Journal:  Ophthalmology       Date:  2009-04-18       Impact factor: 12.079

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.